^
Association details:
Biomarker:AKR1C3 overexpression
Cancer:Hepatocellular Cancer
Drug:OBI-3424 (Alkylating agent)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Title:

A novel AKR1C3 specific prodrug TH3424 with potent anti-tumor activity in liver cancer

Excerpt:
TH3424 showed specific killing of liver cancer cells with AKR1C3 overexpression both in vitro and in vivo…TH3424 is a promising drug candidate for liver cancer and other types of cancers overexpressing AKR1C3.
DOI:
10.1002/cpt.2171